Aemetis (NASDAQ:AMTX) Shares Pass Below Two Hundred Day Moving Average – Should You Sell?

Aemetis, Inc. (NASDAQ:AMTX) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.66 and traded as low as $1.91. Aemetis shares last traded at $1.94, with a volume of 566,085 shares traded.

Analysts Set New Price Targets

AMTX has been the subject of several research reports. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Friday, March 14th. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Wednesday, February 5th. Finally, Ascendiant Capital Markets lifted their price objective on Aemetis from $18.00 to $19.00 and gave the stock a “buy” rating in a research report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Aemetis currently has a consensus rating of “Hold” and a consensus target price of $14.56.

Aemetis Price Performance

The business’s 50 day simple moving average is $2.06 and its 200 day simple moving average is $2.66. The company has a market capitalization of $103.44 million, a PE ratio of -0.86 and a beta of 1.48.

Institutional Investors Weigh In On Aemetis

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC boosted its stake in Aemetis by 1,130.0% during the fourth quarter. Jane Street Group LLC now owns 374,016 shares of the specialty chemicals company’s stock worth $1,006,000 after buying an additional 343,609 shares during the period. State Street Corp lifted its stake in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Aemetis by 515.9% during the fourth quarter. JPMorgan Chase & Co. now owns 120,716 shares of the specialty chemicals company’s stock worth $325,000 after buying an additional 101,116 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in Aemetis in the 4th quarter valued at about $227,000. Finally, Wellington Management Group LLP purchased a new stake in Aemetis during the third quarter worth about $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.